Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating ...

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who ...

Amgen's experimental drug MariTide shows potential for significant weight loss in obese patients, despite notable side ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 ...

Former child star Amanda Bynes confessed that she is using Ozempic for weight loss, hoping to improve her paparazzi photos. She has openly discussed her body image issues and mental health struggles ...

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.

Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of ...